IHT Rendezvous: 'Secret' Arms Deals Provoke Germans

LONDON — There is at least one European export sector that continues to find a ready market around the world — weapons.

In the week in which the European Union received the Nobel Prize for Peace in Oslo, protestors in the Norwegian capital were not alone in pointing out the irony that its member states account for a third of global arms exports.

It is an irony that has a particular resonance in Germany right now, where the government’s decisions on a series of weapons deals have created unease among parliamentarians who complain they were kept in the dark.

Chancellor Angela Merkel, who was among the European leaders in Oslo for Monday’s Nobel award ceremony, has been described as the architect of a new doctrine to boost the country’s weapon sales.

“Germany used to be extremely careful about where it exported its weapons,” wrote Der Spiegel, the German magazine, which has been at the forefront of revelations about Berlin’s weapons policy. “In recent years, however, Chancellor Angela Merkel has shown a preference for sending high-tech armaments abroad rather than German soldiers — even if that means doing business with questionable regimes.”

Legislators and German media have seized on the magazine’s reporting of a secretive federal security committee, chaired by Ms. Merkel, allegedly involved in discussions of high-tech arms sales to countries that include Saudi Arabia, Qatar and Israel.

The latest is the possible sale of state-of-the-art Boxer armored vehicles to the Saudi Royal Guard, which is responsible for protecting the royal family.

Berlin has already approved the sale of up to 270 Leopard 2 tanks to the kingdom in a deal that provoked a fierce debate in Germany.

“Merkel wants to bolster countries that — at least from the German point of view — can provide for stability in their regions,” according to Der Spiegel, which warned it was a risky policy.

But the argument for boosting German weapons exports is economic as much as it is strategic.

“At the end of the day, it’s elementary budgeting,” according to Ben Knight of Deutsche Welle, the German broadcaster.

“Germany, along with most European countries, is in the middle of making drastic cuts in order to bring down its national debt,” he wrote last week. “So instead of costly military operations in the world’s many conflict zones, it has apparently decided to sell more weapons to ‘partner countries’ in those regions. What was once hefty expenditure suddenly becomes vast revenue.”

The so-called Merkel Doctrine has prompted an inevitable backlash from peace advocates and others concerned that German weapons could be used to suppress civil unrest.

Jürgen Grässlin, spokesman for a campaign that opposes arms exports, told Deutsche Welle, “The German government is essentially abetting mass murder in various conflict zones in the world.”

Legislators have also expressed concern that potentially far-reaching decisions are being taken by an inner circle of government without the benefit of parliamentary oversight.

In its latest report on what it described as the secret weapons deals, Der Spiegel this week quoted Markus Löning, the government’s human rights commissioner, as saying, “Citizens have a justified interest in being informed earlier on about arms sales.”

Germany is not alone, of course, in wanting to maximize its weapons sales.

Mark Bromley, a senior researcher at the Stockholm International Peace Research Institute, told Deutsche Welle, “A number of countries in western Europe are seeing declines in defense spending, which is having an impact on both defense acquisitions and production.”

“In an attempt to counter that, several governments — including Germany’s — are getting more focused on the promotion of arms exports to regions where budgets haven’t been cut, including parts of Asia, the Middle East, Africa, and South America.”

As my colleague Judy Dempsey wrote from Berlin earlier this year, not all these markets are in stable, conflict-free, democratic countries.

“This raises the question,” she wrote, “of how Europe can square its commitment to defending human rights with selling weapons to such countries.”

Read More..

Dozens sue pharmacy, but compensation uncertain


NASHVILLE, Tenn. (AP) — Dennis O'Brien rubs his head as he details ailments triggered by the fungal meningitis he developed after a series of steroid shots in his neck: nausea, vomiting, dizziness, drowsiness, blurred vision, exhaustion and trouble with his speech and attention.


He estimates the disease has cost him and his wife thousands of dollars in out-of-pocket expenses and her lost wages, including time spent on 6-hour round trip weekly visits to the hospital. They've filed a lawsuit seeking $4 million in damages from the Massachusetts pharmacy that supplied the steroid injections, but it could take years for them to get any money back and they may never get enough to cover their expenses. The same is true for dozens of others who have sued the New England Compounding Center.


"I don't have a life anymore. My life is a meningitis life," the 59-year-old former school teacher said, adding that he's grateful he survived.


His is one of at least 50 federal lawsuits in nine states that have been filed against NECC, and more are being filed in state courts every day. More than 500 people have gotten sick after receiving injections prepared by the pharmacy.


The lawsuits allege that NECC negligently produced a defective and dangerous product and seek millions to repay families for the death of spouses, physically painful recoveries, lost wages and mental and emotional suffering. Thirty-seven people have died in the outbreak.


"The truth is the chance of recovering damages from NECC is extremely low," said John Day, a Nashville attorney who represents several patients who have been sickened by fungal meningitis.


To streamline the process, attorneys on both sides are asking to have a single judge preside over the pretrial and discovery phases for all of the federal lawsuits.


This approach, called multidistrict litigation, would prevent inconsistent pretrial rulings and conserve resources of all parties. But unlike a class-action case, those lawsuits would eventually be returned to judges in their original district for trial, according to Brian Fitzpatrick, a law professor at Vanderbilt University Law School in Nashville.


Even with this approach, Fitzpatrick noted that federal litigation is very slow, and gathering all the evidence, records and depositions during the discovery phase could take months or years.


"Most of the time what happens is once they are consolidated for pretrial proceedings, there is a settlement, a global settlement between all the lawyers and the defendants before anything is shipped back for trial," he said.


A lawyer representing NECC, Frederick H. Fern, described the consolidation process as an important step.


"A Boston venue is probably the best scenario," Fern said in an email. "That's where the parties, witnesses and documents are located, and where the acts subject to these complaints occurred."


Complicating efforts to recover damages, attorneys for the patients said, NECC is a small private company that has now recalled all its products and laid off its workers. The company's pharmacy licenses have been surrendered, and it's unclear whether NECC had adequate liability insurance.


Fern said NECC has insurance, but they were still determining what the policy covers.


But Day says, "It's clear to me that at the end of the day, NECC is not going to have sufficient assets to compensate any of these people, not even 1 percent."


As a result, many attorneys are seeking compensation from other parties. Among the additional defendants named in lawsuits are NECC pharmacist and co-founder Barry Cadden; co-founder Greg Conigliaro; sister company Ameridose and its marketing and support arm, Medical Sales Management.


Founded in 2006 by Cadden and Conigliaro, Ameridose would eventually report annual revenue of $100 million. An NECC spokesman didn't respond to a request for the pharmacy's revenue.


While Federal Drug Administration regulators have also found contamination issues at Westborough, Mass.-based Ameridose, the FDA has said it has not connected Ameridose drugs to infection or illness.


Under tort law, a lawsuit has to prove a defendant has a potential liability, which in this case could be anyone involved in the medical procedure. However, any such suit could take years and ultimately may not be successful.


"I would not be surprised if doctors, hospitals, people that actually injected the drugs, the people that bought the drugs from the compounding company, many of those people will also be sued," said Fitzpatrick.


Plaintiffs' attorneys said they're considering that option but want more information on the relationships between the compounding pharmacy and the hundreds of hospitals and clinics that received its products.


Day, the attorney in Tennessee, said the clinics and doctors that purchase their drugs from compounding pharmacies or manufacturers could be held liable for negligence because they are in a better position to determine the safety of the medicine than the patients.


"Did they use due care in determining from whom to buy these drugs?" Day said.


Terry Dawes, a Michigan attorney who has filed at least 10 federal lawsuits in the case, said in traditional product liability cases, a pharmaceutical distributor could be liable.


"We are looking at any conceivable sources of recovery for our clients including pharmaceutical supply places that may have dealt with this company in the past," he said.


Ten years ago, seven fungal meningitis illnesses and deaths were linked to injectable steroid from a South Carolina compounding pharmacy. That resulted in fewer than a dozen lawsuits, a scale much smaller than the litigations mounting up against NECC.


Two companies that insured the South Carolina pharmacy and its operators tried unsuccessfully to deny payouts. An appellate court ruled against their argument that the pharmacy willfully violated state regulations by making multiple vials of the drug without specific prescriptions, but the opinion was unpublished and doesn't set a precedent for the current litigation.


The lawsuits represent a way for patients and their families recover expenses, but also to hold the pharmacy and others accountable for the incalculable emotional and physical toll of the disease.


A binder of snapshots shows what life is like in the O'Briens' rural Fentress County, Tenn., home: Dennis hooked up to an IV, Dennis in an antibiotics stupor, bruises on his body from injections and blood tests. He's had three spinal taps. His 11-day stay in the hospital cost over $100,000, which was covered by health insurance.


His wife said she sometimes quietly checks at night to see whether her husband of 35 years is still breathing.


"In my mind, I thought we were going to fight this and get over it. But we are not ever going to get over it," said Kaye O'Brien.


Marjorie Norwood, a 59-year-old grandmother of three who lives in Ethridge, Tenn., has spent just shy of two months total in the hospital in Nashville battling fungal meningitis after receiving a steroid injection in her back. She was allowed to come home for almost a week around Thanksgiving, but was readmitted after her symptoms worsened.


Family members are still dealing with much uncertainty about her recovery, but they have not filed a lawsuit, said their attorney Mark Chalos. He said Norwood will likely be sent to a rehabilitation facility after her second stay in the hospital rather than return home again.


Marjorie Norwood's husband, an autoworker, has taken time off work to care for her and they depend on his income and insurance.


"It doesn't just change her life, it changes everyone else's life around her because we care about her and want her to be happy and well and have everything that she needs," said her daughter, Melanie Norwood.


Read More..

$100-million gift to cover costs for 30-plus UCLA medical students









More than 30 incoming medical school students will get a full ride to UCLA's David Geffen School of Medicine thanks to a $100-million gift from the school's benefactor.


The donation by Geffen, a philanthropist and entertainment executive, will create a scholarship fund to cover the recipients' entire cost of medical school, including tuition, room and board, books and other expenses.


"It is a fantastic vote of confidence for higher education," said UCLA Chancellor Gene Block. "We're eternally grateful."





The gift, which will be announced Thursday, makes Geffen the largest individual donor to UCLA and to any single UC campus. In 2002, Geffen donated $200 million in unrestricted funds to the medical school. At the time, the campus was renamed in his honor.


Geffen, 69, declined to comment but said in a statement that students shouldn't be discouraged by the expense of medical school.


"The cost of a world-class medical education should not deter our future innovators, doctors and scientists from the path they hope to pursue," he said. "We need the students at this world-class institution to be driven by determination and the desire to do their best work and not by the fear of crushing debt. I hope in doing this that others will be inspired to do the same."


More than 85% of medical school students nationwide graduate with some debt. Among those, the average is $170,000, according to the Assn. of American Medical Colleges. That debt often influences graduates' career choices and has contributed to a shortage of primary care doctors, who often earn less than specialists. That shortage will be exacerbated by the aging of the population and the federal expansion of health coverage to the uninsured.


The UCLA scholarships are "unprecedented," said John Prescott, chief academic officer for the association. "My mouth dropped open when I saw this," he said. "It is going to create quite a legacy for the school."


The medical school's dean, A. Eugene Washington, said that he was thrilled by the donation and that it will free scholarship recipients from the tremendous burden of debt. The four-year tab for medical school students entering next fall could exceed $300,000 in tuition, housing, fees and other costs.


The scholarship will allow the school to free up some of the money it uses for financial aid and will enable students to follow their passions and become leading physicians and researchers without worrying about paying off loans, he said. "It is going to be for a group of the top students who will be freed up to pursue whatever their interests are," he said.


The David Geffen Medical Scholarship Fund will provide scholarships for up to 33 students beginning medical school in 2013. Up to three of the scholarships are available for students pursuing a joint doctorate and medical school degree. The students will be chosen based on merit, not financial need.


Block said the scholarships will help recruit more of the nation's top medical school applicants. Already, more than 7,500 applicants compete for 163 first-year slots at the school.


Emily Dubina, 25, a third-year medical school student at UCLA, received a partial scholarship from Geffen's original contribution. The new scholarships, she said, are an amazing opportunity that will take away a lot of the stress of day-to-day life. The recipients will be able to focus on becoming great physicians rather than on how much money they are spending on their education.


"I so wish they had that when I started," she said. "Life would have been much better."


Geffen began his career as a mail room worker at the William Morris Agency in Manhattan and later earned a fortune in the record and movie industries. He formed DreamWorks SKG in 1994 with Jeffrey Katzenberg and Steven Spielberg. He has also become a well-known benefactor, giving to such organizations as the Motion Picture and Television Fund and to the Geffen Playhouse.


anna.gorman@latimes.com





Read More..

Google Maps finally comes to iOS. Again [updated]






Apple has had quite a bumpy car ride so far with it’s mapping product. That all ends in just a couple hours, however, because late Wednesday evening Google is planning on bringing Maps back to iOS with the release of the company’s own software. AllThingsD is reporting that Google’s app will be available for download in the App Store shortly, and we’ll provide some initial thoughts on it soon after.


UPDATE: Google Maps is now available on Apple’s App Store for the iPhone, iPad and iPod touch.






Get more from BGR.com: Follow us on Twitter, Facebook


Gadgets News Headlines – Yahoo! News


Read More..

John McAfee Deported from Guatemala, Back in U.S.















12/13/2012 at 07:50 AM EST







John McAfee in Guatemala


Guatemala's National Police/AP


The latest chapter in the John McAfee saga was written Wednesday, as the anti-virus software pioneer was released from Guatemalan custody and flown to Miami, where he was met by federal officials.

"It was the most gracious expulsion I've ever experienced," McAfee, 67, told ABC News. "Compared to my past two wives that expelled me, this isn't a terrible trip."

He added: "They took me out of my cell and put me on a freaking airplane. I had no choice in the matter."

McAfee is wanted for questioning in the November gunshot murder of a neighbor in Belize. He has denied any wrongdoing, yet fled Belize – going undercover in disguise for several weeks – and sought asylum in Guatemala.

Authorities there arrested him for entering the country illegally. But after an eventful detention, in which McAfee was briefly hospitalized after suffering a nervous collapse, the country evidently felt it prudent to return McAfee to his home soil.

It was not clear Wednesday whether authorities in Miami escorted McAfee away to shield him from the media or because they wanted to question him.

McAfee said he has retained a lawyer in the U.S. and plans to seek a visa for his 20-year-old Belizean girlfriend.

Read More..

DA investigating Texas' troubled $3B cancer agency


AUSTIN, Texas (AP) — Turmoil surrounding an unprecedented $3 billion cancer-fighting effort in Texas worsened Tuesday when its executive director offered his resignation and the state's chief public corruption prosecutor announced an investigation into the beleaguered agency.


No specific criminal allegations are driving the latest probe into the Cancer Prevention and Research Institute of Texas, said Gregg Cox, director of the Travis County district attorney's public integrity unit. But his influential office opened a case only weeks after the embattled agency disclosed that an $11 million grant to a private company bypassed review.


That award is the latest trouble in a tumultuous year for CPRIT, which controls the nation's second-largest pot of cancer research dollars. Amid the mounting problems, the agency announced Tuesday that Executive Director Bill Gimson had submitted his letter of resignation.


"Unfortunately, I have also been placed in a situation where I feel I can no longer be effective," Gimson wrote in a letter dated Monday.


Gimson said the troubles have resulted in "wasted efforts expended in low value activities" at the agency, instead of a focused fight against cancer. Gimson offered to stay on until January, and the agency's board must still approve his request to step down.


His departure would complete a remarkable house-cleaning at CPRIT in a span of just eight months. It began in May, when Dr. Alfred Gilman resigned as chief science officer in protest over a different grant that the Nobel laureate wanted approved by a panel of scientists. He warned it would be "the bomb that destroys CPRIT."


Gilman was followed by Chief Commercialization Officer Jerry Cobbs, whose resignation in November came after an internal audit showed Cobbs included an $11 million proposal in a funding slate without a required outside review of the project's merits. The lucrative grant was given to Dallas-based Peloton Therapeutics, a biomedical startup.


Gimson chalked up Peloton's award to an honest mistake and has said that, to his knowledge, no one associated with CPRIT stood to benefit financially from the company receiving the taxpayer funds. That hasn't satisfied some members of the agency's governing board, who called last week for more assurances that no one personally profited.


Cox said he has been following the agency's problems and his office received a number of concerned phone calls. His department in Austin is charged with prosecuting crimes related to government officials; his most famous cases include winning a conviction against former U.S. House Majority Leader Tom DeLay in 2010 on money laundering charges.


"We have to gather the facts and figure what, if any, crime occurred so that (the investigation) can be focused more," Cox said.


Gimson's resignation letter was dated the same day the Texas attorney general's office also announced its investigation of the agency. Cox said his department would work cooperatively with state investigators, but he made clear the probes would be separate.


Peloton's award marks the second time this year that a lucrative taxpayer-funded grant authorized by CPRIT instigated backlash and raised questions about oversight. The first involved the $20 million grant to M.D. Anderson Cancer Center in Houston that Gilman described as a thin proposal that should have first been scrutinized by an outside panel of scientific peer-reviewers, even though none was required under the agency's rules.


Dozens of the nation's top scientists agreed. They resigned en masse from the agency's peer-review panels along with Gilman. Some accused the agency of "hucksterism" and charting a politically-driven path that was putting commercial product-development above science.


The latest shake-up at CPRIT caught Gilman's successor off-guard. Dr. Margaret Kripke, who was introduced to reporters Tuesday, acknowledged that she wasn't even sure who she would be answering to now that Gimson was stepping down. She said that although she wasn't with the agency when her predecessor announced his resignation, she was aware of the concerns and allegations.


"I don't think people would resign frivolously, so there must be some substance to those concerns," Kripke said.


Kripke also acknowledged the challenge of restocking the peer-review panels after the agency's credibility was so publicly smeared by some of the country's top scientists. She said she took the job because she felt the agency's mission and potential was too important to lose.


Only the National Institutes of Health doles out more cancer research dollars than CPRIT, which has awarded more than $700 million so far.


Gov. Rick Perry told reporters in Houston on Tuesday that he wasn't previously aware of the resignation but said Gimson's decision to step down was his own.


Joining the mounting criticism of CPRIT is the woman credited with brainstorming the idea for the agency in the first place. Cathy Bonner, who served under former Texas Gov. Ann Richards, teamed with cancer survivor Lance Armstrong in selling Texas voters in 2007 on a constitutional amendment to create an unprecedented state-run effort to finance a war on disease.


Now Bonner says politics have sullied an agency that she said was built to fund research, not subsidize private companies.


"There appears to be a cover-up going on," Bonner said.


Peloton has declined comment about its award and has referred questions to CPRIT. The agency has said the company wasn't aware that its application was never scrutinized by an outside panel, as required under agency rules.


___


Follow Paul J. Weber on Twitter: www.twitter.com/pauljweber


Read More..

Brazen N.Y. killing of L.A. man leaves puzzling questions









NEW YORK — Brandon Woodard checked out of his midtown Manhattan hotel room Monday afternoon and emerged onto 58th Street a block from Columbus Circle.


As the 31-year-old Playa Vista man walked down the street, a man standing near a Lincoln sedan pulled a hood over his head as Woodard passed. A short time later, the two passed each other a second time. The man turned, pulled out a gun and shot Woodard at close range in the back of the head with a 9-millimeter pistol. He got back into the Lincoln, which pulled away.


The shooting has riveted New York and made for tabloid headlines. New York police have described the killing as an assassination-style attack.





But it has also reverberated in Los Angeles, where Woodard was raised and made his home.


Woodard grew up in Ladera Heights, played basketball at the exclusive Campbell Hall private high school in Studio City and graduated from Loyola Marymount University in 2003. His stepfather, Rod Wellington, said in an interview Tuesday that Woodard was pursuing a law degree at the University of West Los Angeles School of Law (school officials would not confirm if he was enrolled).


His stepfather described Woodard as a "loving son, a loving father and a loving brother." Woodard had a 4-year-old daughter and had a "great relationship" with the girl and her mother, he said.


"He was a good young man," Wellington said.


But court records revealed a more complex picture. Woodard has been arrested at least 20 times, according to New York Police Commissioner Raymond Kelly.


In 2004, Woodard was cited by Las Vegas police and summoned to court after a backstage scuffle with a security guard at an Usher concert at the Mandalay Bay Hotel and Casino. Police said Woodard had entered a restricted area and refused orders to leave.


He failed to appear in court in connection with the citation and a warrant was issued for his arrest. He was arrested in 2008 on that bench warrant but police could not immediately say how the matter was resolved.


Los Angeles authorities allege that in February 2008 he stole items from a Whole Foods Market and a Gelson's. He was sentenced to nine days in county jail and 200 hours of community service.


In December 2009, he pleaded no contest to a misdemeanor hit-and-run driving charge in Torrance. He received three years and a day in county jail.


Prosecutors said that he came back to court in 2010 and 2011 for probation violation hearings related to arrests for grand theft and battery against a former spouse as well as a spousal battery arrest in January. In April, prosecutors said his probation was completed.


The Los Angeles city attorney's office said there was a hearing related to the September 2010 spousal abuse allegation and noted that a bench warrant had been issued for Woodard's arrest as recently as July 3. It was not immediately clear how the warrant was resolved.


Officials with the Los Angeles County district attorney's office said Woodard was due in Beverly Hills Superior Court on Jan. 22 for a hearing in connection with a single charge of cocaine possession. He was originally charged in June.


Court records also indicated that Woodard's mother had been involved in multiple civil lawsuits related to her real estate business dealings. When Woodard was arrested in January, he listed his occupation as real estate.


Neither police nor family members said they have any idea for a motive.


On Tuesday, Kelly said detectives had made progress in their investigation from ballistics evidence and video surveillance footage that captured the shooting and the suspected getaway vehicle.


He added that investigators were pursuing all leads, including Woodard's criminal history and his family's real estate dealings.


Kelly said Woodard, who carried three cellphones, was believed to be a promoter of some kind, but did not elaborate.


It was not clear what brought Woodard to New York after he purchased a one-way ticket from California, Kelly said, or where he was going when he left the hotel. Woodard checked into the hotel Sunday and checked out about 1:15 p.m. the next day.


Kelly said it was clear the gunman lay in wait for Woodard and didn't act alone.


The suspect had a driver who, after the hit, pulled a silver or gray Lincoln onto 58th Street, Kelly said. Once the gunman was in the car, the vehicle headed south on 7th Avenue and disappeared. A short time later, a car "similar in description" was seen heading through the midtown tunnel eastbound into Queens, where the driver paid the toll with cash.


Investigators had the license plate of the vehicle, but Kelly declined to release the information, citing the ongoing investigation.


Kelly also said ballistics analysis linked the weapon to a 2009 shooting in Queens. The gun was fired at a residence, he said — no one was hurt and no arrests were made.


Kelly said Monday's crime was particularly surprising, given such a public setting.


"You can characterize it as either being brazen or foolhardy," he said.


tina.susman@latimes.comkate.mather@latimes.comandrew.blankstein@latimes.com

Times staff writers Adolfo Flores, Jeff Gottlieb and Frank Shyong contributed to this report. Susman reported from New York, Mather and Blankstein from Los Angeles.





Read More..

Pope Benedict offers blessings with his first tweet






VATICAN CITY (Reuters) – After weeks of anticipation, Pope Benedict sent his first tweet on Wednesday.


“Dear friends, I am pleased to get in touch with you through Twitter. Thank you for your generous response. I bless all of you from my heart.”






The tweet was sent when the 85-year-old pope tapped on a touch screen at the end of his weekly general audience in the Vatican before thousands of people.


(Reporting By Philip Pullella, editing by Paul Casciato)


Internet News Headlines – Yahoo! News


Read More..

The Voice: Team Blake Goes Two-For-Two






The Voice










12/12/2012 at 07:40 AM EST







From left: Judges Adam Levine, Cee Lo Green, Christina Aguilera and Blake Shelton


Trae Patton/NBC


And then there were three – thanks to Tuesday night's episode of The Voice.

Team Blake's Cassadee Pope and Terry McDermott and Team Cee Lo's Trevin Hunte and Nicholas David all awaited their fates during the elimination round to decide the top three, with the coaches seeming to be relieved that they would not have a role in the challenging decision.

McDermott was the first to learn that America's votes had guaranteed him another round of competition. To their coach's delight, Team Blake went two-for-two when Pope joined her teammate in celebration.

While Shelton's team remained intact, Green waited for his contestants' moment of truth. The coaches struggled to say goodbye to either one of the beloved singers.

Christina Aguilera advised Hunte and David to soak up all the lessons they learned on The Voice and move forward no matter what happened. Adam Levine opened up about his own regrets, having not turned his chair around the first time for the singers.

"I have grown to love you as people and love your talent so much," Levine said. "I was wrong not to turn around."

Their coach was also upset. "It's very disheartening and very difficult to see two of my best people on this show being pinned against each other," Green said.

David was the last contestant saved, while Hunte was sent home. "Thank you for pushing and motivating me." Hunte told his coach. "I love you, Cee Lo."

Read More..

IHT Rendezvous: IHT Quick Read: Dec. 11

NEWS Besieged by economic woes and insistent questions about its future, the European Union accepted the Nobel Peace Prize on Monday with calls for further integration and a plea to remember the words of Abraham Lincoln as he addressed a divided nation at Gettysburg. Andrew Higgins reports from Oslo.

North Korea said on Monday that a technical issue had been found in the rocket it had planned to launch as early as this week to put a satellite in orbit, but that it still planned to try the launching by the end of the month. Choe Sang-Hun reports from Seoul.

Some Moroccans wonder whether the Arab Spring brought only cosmetic changes, questioning whether the king and his entourage gave up any of their power. Suzanne Daley reports from Tangier, Morocco.

Italian stock and bond prices fell on Monday after a weekend of political turmoil in Italy gave rise to fears that the country was headed for renewed instability. Shares of Italian banks, which are big holders of the government’s bonds, were among the hardest hit. Elisabetta Povoledo and David Jolly report.

Returns from Romania’s parliamentary elections on Monday gave an overwhelming victory to the center-left alliance of Prime Minister Victor Ponta, leaving the country poised for Round 2 of a political standoff that has destabilized one of the European Union’s newest and poorest members. Dan Bilefsky reports.

Huawei Technologies, a Chinese maker of telecommunications equipment, said on Monday that it planned to open a research and development center in Helsinki next year, accelerating its investments in Europe, where its business is expanding rapidly. Eric Pfanner reports from Paris.

FASHION The Chanel show that Karl Lagerfeld put on last week at Linlithgow Palace, near Edinburgh, was spectacular in every sense of the word. The burning braziers, sending quivering light over old stone, and the dinner held in a tented space, arising like magic on the hillside, were outshone only by an exceptional collection. Suzy Menkes reviews from Edinburgh.

ARTS “Tarzan” is only one of the shows that proves that even out-and-out flops on Broadway can go on to lucrative afterlives in Hamburg, as long as the shows have the spectacle and pageantry that theater producers here say enthrall a German audience. Patrick Healy reports from Hamburg.

SPORTS The essence of Lionel Messi is not in the bare statistic that now makes him the most prolific scorer of goals in a single year in the history of the game. It is in the way that he does it. Rob Hughes reports from London.

Read More..